Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
がんの診断方法と治療方法
Document Type and Number:
Japanese Patent JP5504163
Kind Code:
B2
Abstract:
An object of the present invention is to provide methods for diagnosing and/or treating tumors using HERV-H env gene or HERV-H env protein. Specifically, tumors are diagnosed by detecting expression of HERV-H env gene; and agents for detecting the expression are used as diagnosing agents. Further, tumors are treated by inhibiting function of HERV-H env gene; and agents for inhibiting the function are used as antitumor agents. Furthermore, tumors are treated by administering a peptide having a certain sequence of HERV-H env protein and the like; and the peptide is used as a cancer vaccine.

Inventors:
Chie Kudo
Yutaka Kawakami
Application Number:
JP2010529742A
Publication Date:
May 28, 2014
Filing Date:
September 11, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Keio University
International Classes:
C07K14/15; A61K35/12; A61K35/14; A61K35/15; A61K35/17; A61K35/76; A61K39/00; A61K48/00; A61P35/00; A61P35/02; A61P37/04; C12N5/0783
Domestic Patent References:
JP2007246451A2007-09-27
JP2004502407A2004-01-29
Foreign References:
EP1338606A12003-08-27
WO2006103562A22006-10-05
WO2008011120A22008-01-24
Other References:
JPN6009061708; Marianne Mangeney et.al.: 'The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties' Journal of General Virology Vol.82, 2001, P.2515-2518
JPN6009061709; Mats Lindeskog et. al.: 'Isolation of a human endogenous retroviral HERV-H element with an open env reading frame' Virology Vol.258, 1999, P.441-450
JPN6009061710; Patric Jern et. al.: 'Sequence Variability, Gene Structure, and Expression of Full-Length Human Endogenous Retrovirus H' Journal of Virology Vol.79,No.10, 2005, P.6325-6337
JPN6009061711; Nathalie de Parseval et. al.: 'Characterization of the Three HERV-H Proviruses with an Open Envelope Reading Frame Encompassing the' Virology Vol.279, 2001, P.558-569
JPN6014006234; J. Mol. Med. Vol.85, 2007, P.23-38
JPN6014006236; Cancer Letters Vol.231, 2006, P.228-239
Attorney, Agent or Firm:
Isshiki International Patent Service Corporation